• search
Industry’s Trusted CRDMO Partner Across Europe Industry’s Trusted CRDMO Partner Across Europe

Industry’s Trusted CRDMO Partner Across Europe

Unmatched expertise in drug discovery, development
and scalable manufacturing for small molecule and biologics

Decades of Innovation | Europe-Focused Network | Complete CRDMO Solutions

About Aurigene

Aurigene is committed to accelerating access to affordable and innovative medicines, driven by the belief that good health can't wait. With over 20 years of experience, we offer integrated services across drug discovery, development, and manufacturing (CRDMO) for small molecule and biologics. Our expertise encompasses for Biologics and small molecule, along with peptides, pegylated drugs, steroids, high-potency APIs, and flow chemistry, all backed by advanced technology platforms.

At Aurigene biologics, we deliver a truly end-to-end service offering, from discovery services through CMC process development, clinical scale cGMP manufacture to large scale commercial manufacture of both drug substance and drug product from state-of-the-art facilities inspected by US FDA, EMA, MHRA and dozens of other regulatory authorities. We work with companies around the globe to accelerate their programs.

Know More

Meet our CRDMO experts

We are proud of our world-class team of Europe-based professionals, each bringing extensive expertise in drug discovery, development and manufacturing. With in-depth knowledge of the pharmaceutical and biotech sectors, our experts are dedicated to helping you achieve your drug innovation goals with efficiency and precision.

Kapil Chowdhury

Global Head, Buisness Development

Tania Dey

Tania Dey

Director, Business Development

Kapil Chowdhury

Global Head, Buisness Development

Ashwini Kapoor

Ashwini Kapoor

Director, Business Development

Raj Sharma

Raj Sharma

Director, Business Development

Akshay Ranjan Shukla

Akshay Ranjan Shukla

Sr. Director, Business Development

Why Aurigene Pharmaceutical Services?

20+

years’ experience

900+

scientists

125+

global clients

600+

projects

19

NCEs       
commercialized

16

USFDA inspected       
cGMP facilities

6

Biologics       
commercialized

3

manufacturing countries       
UK, Mexico, India

In the discovery space, Aurigene boasts a legacy of more than 25 years of operations and has long-term partnerships with two of the top five pharmaceutical companies. We offer chemistry, biology, and integrated services across the life cycle of drug discovery, from target identification to IND filing. We operate in a flexible manner and offer our services in FTE and/or FFS mode; integrated and/or standalone mode.

Aurigene Facilities Location

Aurigene Pharmaceutical Service Location MapAurigene Pharmaceutical Service Manufacturing Map
Map pin icon

Hyderabad:

Aurigene Pharmaceutical Services Limited,            
Bollaram Road, Miyapur, Jaya Prakash Narayan Nagar, Miyapur, Telangana 500049

Map pin icon

Bangalore:

Aurigene Pharmaceutical Services Limited,            
39- 40 Hosur Road KIADB Industrial Area, Joggers Ln, Phase 2, Electronic City, Bengaluru, Karnataka 560100

Map pin icon

Visakhapatnam:

APIIC Industrial Estate, Pydibhimavarama (village), Srikakulam district, Andhra Pradesh, India.

Map pin icon

UK: API/ RSM Manufacturing Plant

Steanard Ln, Mirfield W 14 8HZ, United Kingdom

Map pin icon

Mexico:

C.P, Carretera Federal Cuernavaca-Cuautla Km. 4. 5 Colonia CIVAC Jiutepec, 62578 Cuernavaca, Mor. Mexico

Connect with our scientific experts for your drug discovery, development, and manufacturing needs

We understand that clear communication is essential to successful collaborations, and that's why we have a dedicated team that is always ready to help you. Whether you have questions about our services, want to discuss a potential partnership, or simply want to learn more about our company, we're here to help.

Our team of experts is dedicated to providing personalised solutions tailored to your unique needs. So, please don't hesitate to reach out to us. We look forward to hearing from you and helping you achieve your business goals.

Country

section

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

rightCaptcha

Transforming Drug Discovery with Aurigene.AI

Transforming Drug Discovery with Aurigene.AI

In the early 2000s, developing Sovaldi, a hepatitis C treatment, took over a decade and nearly $2 billion. Similarly, Zolgensma, a gene therapy for spinal muscular atrophy, required 15 years due to its complexity. However, the advent of artificial intelligence (AI) has revolutionized drug discovery. For example, in 2022, Pfizer's PAXLOVID, an oral COVID-19 treatm...

Read More
CDMO white paper

Advancement in personalized medicine and how the CRDMO industry is part of the solution

Personalized medicine is transforming the healthcare landscape by customizing treatment plans to individual patients’ unique genetic, clinical and environmental characteristics. These are effective and less invasive treatments for a wide range of conditions. Contract Research, Development and Manufacturing Organizations (CRDMOs) play an important role in enabli...

Read More
Overcoming challenges with cyclic peptides for In-vitro experiments and Bioanalysis

Overcoming challenges with cyclic peptides for In-vitro experiments and Bioanalysis

Project Requirement:Cyclic peptides were to be analyzed for Kinetic solubility, Chrom Log D, MDCK, PAMPA, & Caco2 experiments, while overcoming the challenges associated with the impact of cyclization of peptides on in vitro experiments and bioanalysisWhat were the challenges!1. Nonspecific Binding (NSB)2. Precipitation of peptides while spiking DMSO stock to...

Read More

Development and assessment of a Bcs class II - SGLT2 (Sodium Glucose Cotransporter 2) inhibitor drug in the form of solid lipid Nanoparticles by selecting different lipids, co-surfactants, and manufacturing techniques

2025

Drug Delivery System (DDS) has been used successfully in the past few decades to cure illnesses and enhance health because of its improved systemic circulation and ability to regulate the drug's pharmacological action. As pharmacology and pharmacokinetics advanced, the idea of controlled release emerged, demonstrating the significance of drug release in assessing...

Read More
View All
×

You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.

ProceedBack